A retired U.S. orthopedic surgeon and Founder of R3 Stem Cell, a regenerative medicine company specializing in patient advocacy, marketing and the distribution of post-natal stem cell products obtained from FDA licensed stem cell banks. Dr. Greene is deeply committed to advancing the new Mixed Cell Regenerative Medicine, focusing on patient and provider education with numerous clinical research projects ongoing. In line with the 21st Century Cures Act, mandating that the FDA consider “patient experience data”, thereby making the traditional clinical trials unneccessary to establishing the usefulness of a new therapy, Dr. Greene is on the forefront of advancing stem cell therapies for Americans and is among the few stem cell researchers to recognize the importance of non-cellular compounds such as proteins, cytokines, and growth factors as playing a necessary role in achieving a therapeutic result. Dr. Greene’s proven experience and capability in establishing a network of stem cell providers will be of immense benefit in guiding the Company in future marketing and research campaigns.